Clinical Trial Update: Ferric Carboxymaltose Methemoglobinemia Study

View source ↗

Summary

This completed clinical trial evaluated ferric carboxymaltose in patients with methemoglobinemia and iron-deficiency anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia
• Methemoglobinemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Ordu University | Conditions: Methemoglobinemia, Anemia, Iron-Deficiency | Status: COMPLETED